University of Florida

Fundable SCH


Pharmacy


Note: This data is only an estimate of enrollment figures and is not official enrollment data.
Spring 2011 as of 5/5/2011

  Home | Student Credit Hours | FTE | Enrollment Headcount | Course Management System

Level

Current
SCH
Spring 2011
(5/5/2011)

Closest
Date SCH
Spring 2010
(5/5/2010)

Current/
Closest Date SCH%

End of Term
Spring 2010

Current/
End of Term %

UPPER  

1

7 *

-85.7 %

7 *

-85.7 %

GRAD I  

145

191 *

-24.1 %

191 *

-24.1 %

GRAD II  

18,132

15,954 *

13.7 %

15,954 *

13.7 %

Due to the new Board of Govenors policy regarding Grad I and Grad II hours, Law and Pharmacy are now Grad II programs since they count as professional doctorates in the new IPEDS degree classification system.

* Due to the new Board of Governors policy regarding Grad I and Grad II hours, Law and Pharmacy are now Grad II programs since they count as professional “doctorates” in the new IPEDS degree classification system. These credit hour / FTE adjustments are not reflected in data prior to 9/24/2009.

* Daily enrollment tracking data before 9/13/2010 does not reflect a change in Board of Governors definitions, effective Summer 2010, which requires all Grad I hours for doctoral students to be counted as Grad II hours, regardless of total graduate credit hours earned or possession of a masters degree.

Fundable SCH by Department
Spring 2011

*Note: Due to changes in department account numbers a comparison to last year's data may not be possible.
For those that can be compared the information is displayed below.

Department

Current
SCH
Spring 2011
(5/5/2011)

Closest
Date SCH
Spring 2010
(5/5/2010)

Current/
Closest Date SCH%

End of Term
Spring 2010

Current/
End of Term%

Pha-Medicinal Chemistry  

1,570

1,629

-3.6 %

1,629

-3.6 %

Pha-Pharmaceutical Outcome/Policy  

1,137

1,219

-6.7 %

1,219

-6.7 %

Pha-Pharmaceutics  

2,072

2,188

-5.3 %

2,188

-5.3 %

Pha-Pharmacodynamics  

3,059

3,093

-1.1 %

3,093

-1.1 %

Pha-Pharmacothrpy/Transltnl Rsrch  

10,440

8,023

30.1 %

8,023

30.1 %